Genetic Tests Miss ROS1 Status in Some Advanced NSCLC Cases Genetic Tests Miss ROS1 Status in Some Advanced NSCLC Cases

Orthogonal assays are recommended for fusion testing to make sure patients get optimal targeted therapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news